Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts-Reference-Cited by-同舟云学术

Modulation of Akt vs Stat3 activity by the focal adhesion kinase in non-neoplastic mouse fibroblasts

Published:2021-07 Issue:1 Volume:404 Page:112601
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Geletu Mulu,Adan Hanad,Niit Maximillian,Arulanandam Rozanne,Carefoot Esther,Hoskin Victoria^ORCID,Sina Diana,Elliott Bruce,Gunning Patrick,Raptis Leda

Funder

Natural Sciences and Engineering Research Council of Canada

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Cell Biology

Reference45 articles.

1. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion;Carragher;Trends Cell Biol.,2004

2. FAK in cancer: mechanistic findings and clinical applications;Sulzmaier;Nat. Rev. Canc.,2014

3. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis;Luo;Canc. Lett.,2010

4. Ezrin interacts with focal adhesion kinase and induces its activation independently of cell-matrix adhesion;Poullet;J. Biol. Chem.,2001

5. Cell-cell and cell-matrix adhesion in survival and metastasis: stat3 vs Akt;Niit;Biomol. Concepts,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting STAT3 Enzyme for Cancer Treatment;Mini-Reviews in Medicinal Chemistry;2024-07

2. Differential curcumin absorption and curcumin-induced STAT3 inhibition during 3T3-L1 cell adipogenesis in 2D and 3D cultures;Discover Applied Sciences;2024-01-20

3. The Protective Effect of miRNA-146a Liposome Nanoparticles on Vascular Smooth Muscle Cells After Coronary Intervention;Journal of Biomaterials and Tissue Engineering;2022-11-01

4. Roads to Stat3 Paved with Cadherins;Cells;2022-08-16

5. Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts;Cancer Gene Therapy;2022-04-11